We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Emerson (EMR) Proposes $7.6B Bid for National Instruments
Read MoreHide Full Article
Emerson Electric Co. (EMR - Free Report) has announced its proposal to acquire National Instruments or NI for $53 per share in cash, representing an enterprise value of $7.6 billion.
The deal, which is not subject to any financing conditions, represents a 32% premium over NI’s Jan 12 closing price and a 38% premium over the volume-weighted average price for the last 30 trading days ending Jan 12.
Emerson revealed that the proposal was submitted to NI on Nov 3, 2022, and was an improvement over the initial offer of $48 per share made on May 25, 2022. In a detailed statement, EMR revealed that it had been trying to engage with NI privately over a deal since May 16, 2022, and how it resisted any meaningful discussions for months.
On Jan 13, 2023, NATI announced a strategic review process to explore acquisition interests from other companies. It also adopted a so-called poison pill to protect the company’s interest and that of its shareholders.
Having purchased 2.3 million shares of NI, Emerson has already received regulatory approval to increase its stake. While EMR carries a Zacks Rank #4 (Sell), NI carries a Zacks Rank #3 (Hold).
Emerson’s move to acquire NI is aligned with its focus on global automation to drive growth and profitability. With NI’s premium electronic test and measurement product and software offerings, the acquisition is expected to help EMR offer enhanced solutions to diverse end markets.
In an attempt to transform into a global automation company, Emerson has lately divested several non-core businesses. In November 2022, the company divested its InSinkErator business, a food waste disposers and instant hot water dispensers manufacturer, for $3 billion. In October 2022, EMR sold a majority stake in its Climate Technologies business to private equity funds managed by Blackstone in a $14 billion deal.
Key Picks
Here are some better-ranked stocks that you may consider:
Xylem has an estimated earnings growth rate of 8.8% and 18.5% for 2022 and 2023, respectively. The stock increased 49.6% in the past six months.
IDEX Corporation (IEX - Free Report) presently carries a Zacks Rank #2 (Buy). The company delivered a trailing four-quarter earnings surprise of 5.7%, on average.
IDEX has an estimated earnings growth rate of 28.4% and 6.1% for 2022 and 2023, respectively. Shares of IEX have gained 28% in the past six months.
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Emerson (EMR) Proposes $7.6B Bid for National Instruments
Emerson Electric Co. (EMR - Free Report) has announced its proposal to acquire National Instruments or NI for $53 per share in cash, representing an enterprise value of $7.6 billion.
The deal, which is not subject to any financing conditions, represents a 32% premium over NI’s Jan 12 closing price and a 38% premium over the volume-weighted average price for the last 30 trading days ending Jan 12.
Emerson revealed that the proposal was submitted to NI on Nov 3, 2022, and was an improvement over the initial offer of $48 per share made on May 25, 2022. In a detailed statement, EMR revealed that it had been trying to engage with NI privately over a deal since May 16, 2022, and how it resisted any meaningful discussions for months.
Emerson Electric Co. Price
Emerson Electric Co. price | Emerson Electric Co. Quote
On Jan 13, 2023, NATI announced a strategic review process to explore acquisition interests from other companies. It also adopted a so-called poison pill to protect the company’s interest and that of its shareholders.
Having purchased 2.3 million shares of NI, Emerson has already received regulatory approval to increase its stake. While EMR carries a Zacks Rank #4 (Sell), NI carries a Zacks Rank #3 (Hold).
Emerson’s move to acquire NI is aligned with its focus on global automation to drive growth and profitability. With NI’s premium electronic test and measurement product and software offerings, the acquisition is expected to help EMR offer enhanced solutions to diverse end markets.
In an attempt to transform into a global automation company, Emerson has lately divested several non-core businesses. In November 2022, the company divested its InSinkErator business, a food waste disposers and instant hot water dispensers manufacturer, for $3 billion. In October 2022, EMR sold a majority stake in its Climate Technologies business to private equity funds managed by Blackstone in a $14 billion deal.
Key Picks
Here are some better-ranked stocks that you may consider:
Xylem Inc. (XYL - Free Report) delivered a trailing four-quarter earnings surprise of 13.3%, on average. XYL presently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks.
Xylem has an estimated earnings growth rate of 8.8% and 18.5% for 2022 and 2023, respectively. The stock increased 49.6% in the past six months.
IDEX Corporation (IEX - Free Report) presently carries a Zacks Rank #2 (Buy). The company delivered a trailing four-quarter earnings surprise of 5.7%, on average.
IDEX has an estimated earnings growth rate of 28.4% and 6.1% for 2022 and 2023, respectively. Shares of IEX have gained 28% in the past six months.